 RNAi Therapeutics
"RNAi Therapeutics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE.
| Descriptor ID |
D000067492
|
| MeSH Number(s) |
E02.095.301.250
|
| Concept/Terms |
RNAi Therapeutics- RNAi Therapeutics
- RNAi-Based Therapeutics
- RNAi-Based Therapy
- RNAi Based Therapy
- RNAi-Based Therapies
- Therapies, RNAi-Based
- Therapy, RNAi-Based
- RNAi Therapy
- RNAi Therapies
- Therapies, RNAi
- Therapy, RNAi
|
Below are MeSH descriptors whose meaning is more general than "RNAi Therapeutics".
Below are MeSH descriptors whose meaning is more specific than "RNAi Therapeutics".
This graph shows the total number of publications written about "RNAi Therapeutics" by people in this website by year, and whether "RNAi Therapeutics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "RNAi Therapeutics" by people in Profiles.
-
Shah VN, Pyle L. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med. 2021 11 11; 385(20):e69.
-
Bender H, Noyes N, Annis JL, Hitpas A, Mollnow L, Croak K, Kane S, Wagner K, Dow S, Zabel M. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment. PLoS One. 2019; 14(7):e0219995.
-
Robertson SA. Preventing Preeclampsia by Silencing Soluble Flt-1? N Engl J Med. 2019 03 14; 380(11):1080-1082.
-
Wang LL, Chung JJ, Li EC, Uman S, Atluri P, Burdick JA. Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart. J Control Release. 2018 09 10; 285:152-161.
-
Muralidharan R, Babu A, Amreddy N, Basalingappa K, Mehta M, Chen A, Zhao YD, Kompella UB, Munshi A, Ramesh R. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration. J Nanobiotechnology. 2016 Jun 21; 14(1):47.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|